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Gut-friendly B cells?
On page 1343, Shimomura et al. identify a group of B cells that 
rebels against convention: unlike other B cells, this group matures 
in the gut and might protect it from inflammatory damage.
B cells are thought to mature in the bone marrow and spleen. 
As they mature, B cells express the immunoglobulin receptor IgM, 
which distinguishes them from their antigen-activated brethren. 
The activated cells are mostly found in gut lymphoid tissues, 
where they secrete antibodies.
The mouse gut, however, also contains IgM+ B cells, which 
increase in number during inflammation. These cells were assumed 
to be either antigen-inexperienced cells that were just passing 
through or antigen-activated immigrants that hadn’t yet matured.
But Shimomura et al. now find that the gut IgM+ B cells did 
not express the same pattern of cellular receptors that mark 
B cells that mature elsewhere, suggesting that that these cells may 
be long-term gut residents. The authors found IgM+ gut cells in mice that lacked spleens, gut lymphoid 
tissues, or inflammation—conditions that deter activated B cells from entering and surviving in the gut.
The cells also differed from other B cells in their ability to survive in the absence of antigen. 
They only needed the cytokine BAFF, which helps B cells transit through developmental checkpoints. 
And although the IgM+ cells multiplied during inflammation, the expanded population included a 
diversity of clones instead of a narrow, antigen-specific repertoire.
The function of these cells is still unclear, but the study offers some clues. The cells expanded only as 
the inflammation was dying down, and in response to innate immune receptor activation, they secreted 
IL-12—a cytokine that tempers chronic gut inflammation. The authors propose that these IgM+ B cells, 
which can also produce the suppressive cytokine IL-10, may be the precursors of regulatory B cells 
previously associated with chronic gut inflammation. 
On page 1381, Lochner et al. expose the 
promiscuity of a transcription factor that 
was previously thought to be exclusive to 
inflammatory T helper (Th) 17 cells. 
They now find that this protein is also 
expressed by a group of regulatory T (T 
reg) cells that keeps Th17 cells in line.
Both cell types stem from naive 
CD4+ T cells, depending on the cyto-
kines in attendance: T reg cells are in-
duced by high levels of TGF-β, whereas 
inflammatory Th17 cells are induced by 
lower levels of TGF-β and IL-6. Each 
subset foils the other by secreting cyto-
kines with opposite functions. When T reg 
cells are missing, mice have more Th17 
cells and develop inflammatory diseases, 
suggesting that one subset might limit 
the other to maintain health.
Th17 cells were previously detected 
based on their expression of the transcrip-
tion factor RORγt, which is required for 
their development. But Lochner et al. 
now find that in healthy mice, the 
RORγt+ T cell population includes a 
group of cells that does not produce the 
signature Th17 cytokine IL-17 when 
activated. These cells instead secreted the 
suppressive cytokine IL-10 and expressed 
the T reg cell–specific transcription factor 
Foxp3 alongside RORγt.
These RORγt-expressing T reg cells 
expressed ligands for chemokine recep-
tors found on Th17 cells. Mice that 
lacked these receptors had more Th17 
cells, suggesting that the T reg cells 
might lure the inflammatory cells into a 
suppressive environment.
The T reg cells also controlled their 
nemeses in a more direct way. In 
RORγt+ T reg cells, RORγt was bound 
by Foxp3, suggesting that Foxp3 may 
actively derail Th17 development. Con-
sistent with this idea, naive CD4+ T cells 
cultured with TGF-β alone first ex-
pressed RORγt and later expressed 
Foxp3, which drove them to become 
T reg cells. The delayed induction of 
Foxp3 could be prevented by IL-6, thus 
freeing RORγt to drive Th17 differenti-
ation. Whether suppressive cytokines can 
reverse this switch is yet to be determined.
Both RORγt-expressing popula-
tions were present in equal numbers in 
most tissues of healthy mice, suggesting 
mutual control between the two cell 
types. Both populations expanded pro-
portionally in response to inflammation 
or infection, which is probably important 
to ensure a damage-free recovery. 
IgM+ B cells (brown) develop in the mouse gut even when the spleen 
and gut lymphoid tissues are missing.
Balanced T cell subsets for good health
The naive RORγt+ T cell population (green) 
includes Foxp3-expressing regulatory T cells 
(arrowheads).